More on BRVE

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (10.0 Score)

Upcoming Events

- Earnings (12/2/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

(NQ:BRVE)
Delayed: 23.41 -0.2 (0.85%)
Prev. Close $23.61  
Open$23.21 
52 Wk High$ 
52 Wk Low$ 
Day High$23.77 
Day Low$23.07 
P/E N/A  
EPS$ 
Volume59,814 


Sep 16, 2026 04:30 PM Braveheart Bio to Participate in Stifel Cardiometabolic Forum
Sep 14, 2026 07:51 AM Goldman Sachs Reiterates Buy Rating on Braveheart Bio (BRVE)
Sep 9, 2026 09:35 AM Stifel Reiterates Buy Rating on Braveheart Bio (BRVE)
Sep 8, 2026 04:03 PM Braveheart Bio Reports Second Quarter 2026 Financial Results and Provides Business Update
Sep 1, 2026 04:30 PM Braveheart Bio to Participate in Cantor Global Healthcare Conference
Aug 31, 2026 06:58 AM Jefferies starts biopharma firm Braveheart at Buy after IPO
Aug 31, 2026 06:18 AM Cantor Fitzgerald Starts Braveheart Bio (BRVE) at Overweight
Aug 31, 2026 05:29 AM TD Cowen Starts Braveheart Bio (BRVE) at Buy
Aug 31, 2026 02:50 AM Stifel Starts Braveheart Bio (BRVE) at Buy
Aug 31, 2026 02:49 AM Jefferies Starts Braveheart Bio (BRVE) at Buy
View All Articles

Entities mentioned with BRVE

View All Entities